Open AccessCOVID-19 Outcomes in Solid Organ Transplant Recipients Who Received Tixagevimab-cilgavimab Prophylaxis and/or Bebtelovimab Treatment in a Nurse-driven Monoclonal Antibody Program During the Omicron Surge
Author(s) -
Willa Cochran,
Sonsoles SaltoAlejandre,
Lindsay Barker,
Julie Langlee,
Kristin Freed,
Debra Carter,
Jaclyn Ban,
Dillon Goddard,
Heba H. Mostafa,
William A Werbel,
Pali D. Shah,
Dorry L. Segev,
Daniel C. Brennan,
Robin K. Avery
Publication year - 2022
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000004418
Subject(s) - medicine , dosing , demographics , medical record , incidence (geometry) , emergency medicine , covid-19 , pediatrics , infectious disease (medical specialty) , disease , demography , physics , sociology , optics